Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Biodel, Inc.
Pharmaceutical Preparations CT, United States
Nasdaq: BIOD
Company Description
Biodel, Inc. is a development stage biopharmaceutical company. It is focused on the development and commercialization of innovative treatments for diabetes. The company develops product candidates by applying its proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles. It develops novel forms of insulin and other peptide hormones for use in treating diabetes and its complications, including hyperglycemia, hypoglycemia, cardiovascular complications and weight control. Biodel was founded by Solomon S. Steiner and Erik I. Steiner on December 3, 2003 and is headquartered in Danbury, CT.
Similar to: BioGaia AB, United-Guardian, Inc., Sareum Holdings Plc
Featured Company
Pool Corp.
Covington, LA, US
Pool Corp. markets and distributes swimming pool supplies and related products. It offers maintenance products, repair & replacement… Learn more →
Social Monitor
You may also be interested in:
Sareum Holdings Plc
Cambridge, EA, GB
Sareum is a drug discovery company, headquartered in Cambridge UK, that produces targeted small molecule therapeutics, focusing on… Learn more →
United-Guardian, Inc.
Hauppauge, NY, US
United-Guardian, Inc. engages in the research, development, manufacture, and marketing of cosmetic ingredients, personal and health… Learn more →
BioGaia AB
Stockholm, SE
BioGaia develops, markets and sells probiotic products with documented health benefits. Its products are primarily based on different… Learn more →